Decrypting the USP22-homologous DUB network to sensitize pancreatic cancer for STING-mediated necroptosis
Decrypting the USP22-homologous DUB network to sensitize pancreatic cancer for STING-mediated necroptosis
批准号:
426710085
负责人:
Privatdozent Dr. Sjoerd van Wijk
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
--
资助国家:
德国
项目状态:
未结题
起止时间:
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Necroptosis is a lytic form of programmed cell death (PCD) involved in infection, inflammation and tumor formation. Pancreatic cancer (PC) has an extremely dismal prognosis, but interferon (IFN)- and STING-induced necroptosis potentially serves as attractive therapeutic option to target chemotherapy- and apoptosis-resistant PC. A central determinant of necroptosis is the RIPK3-dependent phosphorylation of MLKL, leading to MLKL oligomerization, membrane accumulation and permeabilization, ultimately triggering cell death. Ubiquitination of RIPK3 and MLKL fine-tunes necroptosis, but the underlying mechanisms, E3 ligases and deubiquitinating enzymes remain largely unexplored. Our published and preliminary data identify USP22 as novel DUB that controls necroptosis via RIPK3 and MLKL ubiquitination and reveal USP22 as negative regulator of tonic IFN signaling, STING ubiquitination and STING-induced necroptosis. The current dogma states that USP22 is embedded in the SAGA complex to control gene transcription via regulating histone H2B mono-ubiquitination, but our findings suggest novel, SAGA-independent roles of USP22. Of note, the two highly USP22-homologous DUBs USP51 and USP27X function together with USP22, but the mechanisms, regulation and functional relevance of the USP22-USP51-USP27X network for (STING-mediated) necroptosis remain unclear. This proposal therefore aims to understand the cellular and biological relevance of the USP22-homologous DUB network in controlling necroptosis and how this network can be targeted to sensitize PC for STING-mediated necroptosis. To this end, we will use multidisciplinary state-of-the-art imaging systems, including 3D light-sheet fluorescence microscopy and laser scanning fluorescence microscopy, with advanced proximity interactome mass-spectrometry and in-depth analysis of necroptosis in healthy and tumorigenic primary human pancreatic organoids. Due to species-specific differences in RIPK3-MLKL signaling, analyzing the USP22-USP51-USP27X network in necroptosis will not only be extremely relevant for the fundamental research fields of PCD, gene transcription and organoids, but also has translational relevance by sensitizing apoptosis-resistant PC for STING-mediated necroptosis. This competitive research approach therefore offers highly innovative and informative approaches to unravel novel compartment- and protein complex-specific roles of the homologous USP22-USP51-USP27X triad. At the same time, this knowledge will be used in translational settings to combat PC by reprogramming ubiquitination, STING function and PCD sensitivities in clinically relevant and near-physiological, multicellular human organoids.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
UNRAVELING THE DUB NETWORK THAT CONTROLS DEATH RECEPTOR INDUCED CELL SURVIVAL AND DEATH PATHWAYS
-
批准号:414826869
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Privatdozent Dr. Sjoerd van Wijk
-
依托单位:
Investigating the role of OTULIN and the regulation of linear ubiquitination in the pathogenesis of Activated B-Cell-like Diffuse Large B-Cell Lymphoma
-
批准号:494877499
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Privatdozent Dr. Sjoerd van Wijk
-
依托单位:
国内基金
海外基金
登录
查看更多内容
KAT2A介导的USP22琥珀酰化通过稳定SOX4促进结直肠癌进展的分子机制研究
-
批准号:2026JJ82028
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:程发辉
-
依托单位:
USP22通过去泛素稳定GRB7促进结直肠癌发展的机制研究
-
批准号:2026JJ60159
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:鞠昭
-
依托单位:
补阳还五汤通过调控USP22–Beclin1信号轴干预自噬依赖性铁死亡缓解脑缺血再灌注损伤的机制研究
-
批准号:2026JJ80615
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:郑春茂
-
依托单位:
USP22通过去泛素化PTGS2调控铁死亡促进非酒精性脂肪性肝病进程的机制研究
-
批准号:2026JJ81889
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王卓雅
-
依托单位:
USP22/mTOR/自噬对肝缺血再灌注损伤的调控及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:王京瑞
-
依托单位:
去泛素化酶USP22介导SGLT2抑制剂对抗心肌细胞衰老延缓糖尿病心肌病的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:庄晓东
-
依托单位:
去泛素化酶USP22在妊娠期糖尿病发病中作用及分子机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:许丹
-
依托单位:
基于类器官模型研究泛素特异性肽酶 22(USP22)调控组蛋白乳酸化修饰在卵
巢癌铂类耐药中的机制
-
批准号:24ZR1465200
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:王子良
-
依托单位:
USP22表达下调介导巨噬细胞M2极化受阻促进桥本甲状腺炎进展的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
USP22 促进 TRRAP 去泛素化调节巨噬细胞脂
代谢重编程影响动脉粥样硬化进展的机制研
究
-
批准号:TGY24H020031
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:毛萍
-
依托单位: